The Predictive Value of Extracellular Volume Fraction Derived from Enhanced CT Combined with Systemic Immune-Inflammation Index for Tumor Budding in Rectal Cancer
Technology in Cancer Research & Treatment · 2026
DOI: 10.1177/15330338261426699 ↗Kurz gefasst
Fachartikel in der Zeitschrift Technology in Cancer Research & Treatment, 2026. Verfasst von Wei Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of medical imaging, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huai'an, China. Hauptthemen laut MEDLINE: Rectal Neoplasms, Tomography, X-Ray Computed, Inflammation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
To explore the value of enhanced computed tomography (CT) -derived extracellular volume (ECV) combined with systemic immune-inflammation index (SII) in predicting tumor budding (TB) grading of rectal cancer. Materials and Methods The clinical and imaging data of 177 rectal cancer patients were retrospectively analyzed, and we divided them into a low-grade and medium-high group according to pathological TB count. ECV and SII values between the two groups were compared. Intra-class correlation coefficient (ICC) was used to detect the consistency of measurements among observers. Binary logistic regression was used to analyze the correlations between variables and TB grading of rectal cancer. Receiver operating characteristic (ROC) curve analysis was performed to evaluate the diagnostic efficiency of statistically significant parameters and their combination. Area under the curve (AUC), its 95% confidence interval, and the corresponding Youden index, sensitivity, and specificity were calculated.
Results
Among the 177 rectal cancer patients, 108 were low-grade and 69 were medium-high grade. ECV values measured by two physicians showed good consistency (ICC = 0.98). ECV value of low-grade (21.76% ± 4.89%) was lower than that of medium-high grade TB group (27.91% ± 4.77%) (P < .001). SII value was lower in low-grade group (492.14 ± 239.56) than in medium-high grade TB group (825.02 ± 529.38). In the multivariate analysis, ECV value [odds ratio (OR): 1.339 (95% CI: 1.194-1.502)] and SII value [OR: 1.004 (95% CI: 1.002-1.005)] were independent risk factors for predicting TB grading. In the training set, AUCs of ECV, SII, and their combination in evaluating TB grading of rectal cancer were 0.838 (95% CI: 0.760-0.905), 0.755 (95% CI: 0.663-0.829), and 0.889 (95% CI: 0.832-0.943), respectively. In the test set, the corresponding AUCs were 0.741 (95% CI: 0.626-0.870), 0.716 (95% CI: 0.554-0.849), and 0.815 (95% CI: 0.711-0.913). Decision curve analysis (DCA) showed that the combination had higher clinical value than using ECV or SII alone.
Conclusion
The combination of ECV and SII can non-invasively evaluate TB grading of rectal cancer before surgery, potentially providing a reference for preoperative risk stratification as a decision-support tool.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of medical imaging, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huai'an, China.
ORCID-Profile: Yating Wang, Genji Bai
Zitieren
APA
Chen, W., Wang, Y., Bai, G., Huang, W., & Huang, M. (2026). The Predictive Value of Extracellular Volume Fraction Derived from Enhanced CT Combined with Systemic Immune-Inflammation Index for Tumor Budding in Rectal Cancer. Technology in Cancer Research & Treatment. https://doi.org/10.1177/15330338261426699
Vancouver
Chen W, Wang Y, Bai G, Huang W, Huang M. The Predictive Value of Extracellular Volume Fraction Derived from Enhanced CT Combined with Systemic Immune-Inflammation Index for Tumor Budding in Rectal Cancer. Technology in Cancer Research & Treatment. 2026. doi:10.1177/15330338261426699
BibTeX
@article{Chen2026,
author = {Chen, Wei and Wang, Yating and Bai, Genji and Huang, Wei and Huang, Min},
title = {The Predictive Value of Extracellular Volume Fraction Derived from Enhanced CT Combined with Systemic Immune-Inflammation Index for Tumor Budding in Rectal Cancer},
journal = {Technology in Cancer Research & Treatment},
year = {2026},
doi = {10.1177/15330338261426699}
}
EUVIMED